Close Menu

NEW YORK – The American College of Medical Genetics and Genomics said today that all breast cancer patients should be evaluated to determine if they should receive germline genetic testing for assessing their inherited risk for the disease. 

However, the medical genetics professional organization doesn't recommend testing all breast cancer patients for germline pathogenic or likely pathogenic variants in BRCA1, BRCA2, and other breast cancer-linked genes. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.